About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2019 NCCN Policy Summit
2019 MASCC/ISOO Annual Meeting
2019 ASCO Annual Meeting
ESMO World GI 2019
2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Harvey J. Cohen, MD"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
Mortality Risk for Patients With Preexisting Cardiovascular Conditions Treated With Abiraterone Acetate or Enzalutamide
Pooled Analysis of 4-Year Survival With Nivolumab Therapy in Patients With Previously Treated Advanced NSCLC
Surgical Resection Among Patients Receiving Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
Does Exercise Improve Outcomes in Patients With Metastatic Colorectal Cancer?
FDA OCE and Syapse Announce Research Collaboration Focused on Regulatory Use of Real-World Evidence
Most Read Stories
BEACON CRC: Encorafenib/Binimetinib/Cetuximab Improves Survival in
V600E–Mutated Metastatic Colorectal Cancer
Management of HER2-Positive Breast Cancer: Business as Usual?
Notable Presentations at ASCO 2019 Included Studies in Sarcoma, Lymphoma, Myeloma, and Breast and Kidney Cancers
FDA Approves Fedratinib for Myelofibrosis
© 2019 HSP News Service, L.L.C.